Swipe om te navigeren naar een ander artikel
The Alcohol Quality of Life Scale (AQoLS) is a new patient-reported outcome 34-item questionnaire measuring health-related quality of life (HRQOL), specific to patients with an alcohol use disorder, developed from the patients’ perspective. This is the first report establishing evidence in support of measurement reliability and validity of the AQoLS.
A total of 285 randomly selected patients receiving interventions for alcohol use disorder in addiction specialised care settings in France were included in the study (response rate 80.1 %). Exploratory factor analysis was conducted to evaluate the hypothesised-during-development-stage dimensional structure of the AQoLS. Internal consistency of the total score and the dimensions subscores were assessed through Cronbach’s alpha coefficients. Construct validity was tested through correlations with the Short-Form 36 Health Survey (SF-36) and EuroQol 5 dimensions (EQ-5D).
Exploratory analysis indicated seven observed dimensions which differed slightly from the 7 dimensions defined a priori in the framework hypothesised during the scale development: activities, relationships, living conditions, negative emotions, self-esteem, control and sleep. A major common factor allows the summing of the 34 items to obtain a total score. All the 34 items were acceptable. Cronbach’s alpha for the AQoLS total score was 0.96 and ranged from 0.8 to 0.9 for the dimensions subscores. Negative correlations between AQoLS and all dimensions of the SF-36, but general health and positive correlations between AQoLS and all items of the EQ-5D were shown. As expected, the correlations were mostly moderate in magnitude, low with scores referring to physical areas and the highest with the SF-36 MSC.
This study provides evidence of the measure’s psychometric properties in terms of construct validity and internal consistency. The “control” and “self-esteem” dimensions are of particular interest as these concepts are not captured in existing HRQOL. Further longitudinal validation of the scale is necessary to assess sensitivity to change.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
SAMHSA. (2012). Results from the 2011 National survey on drug use and health: Mental health findings. In NSDUH Series H- 45. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality.
EMA. (2010). Guideline on the development of medicinal products for the treatment of alcohol dependence. European Medicines Agency.
EMA-CHMP. (2012). Selincro Assessment report.
EuropeanMedicinesAgency. (2013). Selincro (nalmefene): EU summary of product characteristics.
FDA. (2015). Alcoholism: Developing drugs for treatment guidance for industry draft guidance. Center for Drug Evaluation and Research (CDER).
Miller, W.R., & Longabaugh, R. The drinker inventory of consequences (DrInC) An instrument for assessing adverse consequences of alcohol abuse. Test Manual. In Project MATCH Monograph Series. 1995, National Institute on Alcohol Abuse and Alcoholism.
Donovan, D., et al. (2005). Quality of life as an outcome measure in alcoholism treatment research. Journal of Studies on Alcohol, 15, 119–139. (discussion 92–93). CrossRef
Drummond, M. F., et al. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford: Oxford University Press.
Raistrick, D., Heather, N., & Godfrey, C. (2006). Review of the effectiveness of treatment for alcohol problems: NHS, National Treatment Agency for Substance Misuse. NHS, National Treatment Agency for Substance Misuse.
Leplege, A. (2011). Measurements of quality of life, construction and validation of an instrument. Soins, 759, 35–37. PubMed
EuroQolGroup. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208. CrossRef
Jeanrenaud, C., et al. (2003). Le coût social de l’abus d’alcool en Suisse. Institut de recherches économiques et régionales—Université de Neuchatel.
Luquiens, A., et al. (2012). Development of a patient reported outcome measure for alcohol use disorder, in ISBRA. Japan: Sapporo.
FDA. (2009). Guidance for industry. Patient- reported outcome measures: Use in medical product development to support labeling claims.
Mokkink, L. B., et al. (2012). COSMIN checklist manual. Amsterdam: EMGO Institute for Health and Care Research.
Streiner, D. L., Norman, G. R., & Cairney, J. (2014). Health measurement scales: A practical guide to their development and use. Oxford: Oxford University Press. CrossRef
De Vet, H., et al. (2011). Measurement in medicine: A practical guide. Cambridge: Cambridge University Press. CrossRef
Piazza, P. V., & Deroche-Gamonet, V. (2013). A multistep general theory of transition to addiction. Psychopharmacology (Berl), 229(3), 387–413. CrossRef
Rosenberg, M. (1965). Society and the adolescent self image. New Jersey: Princeton University Press.
Chubon, R. (1999). Manual for the life situation survey. Department of neuropsychiatry and behaviorial Science, University of South Carolina.
Wallhed Finn, S., Bakshi, A. S., & Andreasson, S. (2014). Alcohol consumption, dependence, and treatment barriers: Perceptions among nontreatment seekers with alcohol dependence. Substance Use & Misuse, 49(6), 762–769. CrossRef
Hsu, D.T., et al. (2015). It still hurts: Altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry.
Whalley, D., et al. (2014). Cultural adaptation of the Alcohol Quality of Life Scale for use in Japan, China, and Korea. In International Society For Pharmacoeconomics and Outcomes Research, 17th Annual European Congress. Amsterdam.
- Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: the Alcohol Quality of Life Scale (AQoLS)
H. J. Aubin
- Springer International Publishing